Transparency in Reimbursement Decisions: In Whose Best Interest?
Do Changes in Drug Coverage Policy Point to an Increased Role for Cost-Effectiveness Analysis in the USA?
Modelling the Cost Effectiveness of Interventions for Osteoporosis: Issues to Consider
Economic Evaluations of Gastroesophageal Reflux Disease Medical Management
A Review of the Psychometric Properties of Generic Utility Measures in Multiple Sclerosis
Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
The Better than Dead Method: Feasibility and Interpretation of a Valuation Study
A Cost-effectiveness Study of Intravenous Immunoglobulin in Childhood Idiopathic Thrombocytopenia Purpura Patients with Life-Threatening Bleeding